Evidence map›Paper›PMID 22228764›Full record

ArticleThe Journal of biological chemistry2012

Reductive activation of type 2 ribosome-inactivating proteins is promoted by transmembrane thioredoxin-related protein.

Matteo Pasetto, Erika Barison, Monica Castagna, Pietro Della Cristina, Cristina Anselmi, Marco Colombatti

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. How Are Proteins Reduced in the Endoplasmic Reticulum?Trends in biochemical sciences · 2018
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Matteo PasettoDepartment of Pathology and Diagnostics, Section of Immunology, University of Verona, Policlinico G. B. Rossi, P. le L. Scuro 10, 37134 Verona, Italy. biomatteo@tin.it
Erika Barison
Monica Castagna
Pietro Della Cristina
Cristina Anselmi
Marco Colombatti
University of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Members of the type 2 ribosome-inactivating proteins (RIPs) family (e.g. ricin, abrin) are potent cytotoxins showing a strong lethal activity toward eukaryotic cells. Type 2 RIPs contain two polypeptide chains (usually named A, for "activity", and B, for "binding") linked by a disulfide bond. The intoxication of the cell is a consequence of a reductive process in which the toxic domain is cleaved from the binding domain by oxidoreductases located in the lumen of the endoplasmic reticulum (ER). The best known example of type 2 RIPs is ricin. Protein disulfide isomerase (PDI) was demonstrated to be involved in the process of ricin reduction; however, when PDI is depleted from cell fraction preparations ricin reduction can still take place, indicating that also other oxidoreductases might be implicated in this process. We have investigated the role of TMX, a transmembrane thioredoxin-related protein member of the PDI family, in the cell intoxication operated by type 2 RIPs ricin and abrin. Overexpressing TMX in A549 cells resulted in a dramatic increase of ricin or abrin cytotoxicity compared with control mock-treated cells. Conversely, no difference in cytotoxicity was observed after treatment of A549 cells or control cells with saporin or Pseudomonas exotoxin A whose intracellular mechanism of activation is not dependent upon reduction (saporin) or only partially dependent upon it (Pseudomonas exotoxin A). Moreover, the silencing of TMX in the prostatic cell line DU145 reduced the sensitivity of the cells to ricin intoxication further confirming a role for this enzyme in intracellular ricin activation.

Indexed as

AbrinADP Ribose TransferasesBacterial ToxinsChemical Warfare AgentsEndoplasmic ReticulumExotoxinsHumansJurkat CellsMembrane ProteinsOxidation-ReductionProtein Disulfide-IsomerasesProtein Synthesis InhibitorsPseudomonas aeruginosa Exotoxin ARibosome Inactivating Proteins, Type 1RicinSaporinsAbrinADP Ribose TransferasesBacterial ToxinsChemical Warfare AgentsExotoxinsMembrane ProteinsProtein Disulfide-IsomerasesProtein Synthesis InhibitorsPseudomonas aeruginosa Exotoxin ARibosome Inactivating Proteins, Type 1RicinSaporinsThioredoxinsTMX1 protein, humanVirulence Factors

Identifiers

PMID22228764
PMCPMC3293526
OpenAlexW2007026737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.